MENU
ACIU
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
AC Immune SA (ACIU) Earnings Date & Reports
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases... Show more
Industry: #Pharmaceuticals Major
A.I. Advisor
published Earnings
ACIU is expected to report earnings to fall 52.21% to -6 cents per share on July 30
Q2'26
Est.
$-0.07
Q4'25
Beat
by $0.02
Q3'25
Beat
by $0.03
Q2'25
Missed
by $0.04
Q1'25
Beat
by $0.01
The last earnings report on March 13 showed earnings per share of -14 cents, beating the estimate of -15 cents. With 259.24K shares outstanding, the current market capitalization sits at 260.54M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of therapeutic and diagnostic products to prevent and modify diseases caused by misfolding proteins
Industry Biotechnology
Profile
Details
Industry
Pharmaceuticals Major
Address
EPFL Innovation Park
Phone
+41 213459121
Employees
161
Web
https://www.acimmune.com